RecruitingNot ApplicableNCT06340217

Washed Microbiota Transplantation for Diabetic Gastroparesis

The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

Sponsor

The Second Hospital of Nanjing Medical University

Enrollment

46 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetic Gastroparesis

Summary

This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying placebo and washed microbiota transplantation for people with diabetic gastroparesis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERwashed microbiota transplantation

Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive two doses of WMT for DGP.

OTHERplacebo

A carrier fluid with matching volume and consistent appearance to the infusion of washed microbiota.